At the time of writing, Dexcom Inc [DXCM] stock is trading at $75.34, up 0.35%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The DXCM shares have lost -8.41% over the last week, with a monthly amount drifted -6.72%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dexcom Inc [NASDAQ: DXCM] stock has seen the most recent analyst activity on August 21, 2025, when Argus initiated its Buy rating and assigned the stock a price target of $100. Previously, Truist started tracking the stock with Buy rating on June 16, 2025, and set its price target to $102. On May 30, 2025, Goldman initiated with a Buy rating and assigned a price target of $104 on the stock. Mizuho started tracking the stock assigning a Outperform rating and suggested a price target of $85 on April 10, 2025. Redburn Atlantic upgraded its rating to a Buy and raised its price target to $115 on February 03, 2025. Robert W. Baird upgraded its rating to Outperform for this stock on January 16, 2025, and upped its price target to $104. In a note dated July 26, 2024, Robert W. Baird downgraded a Neutral rating on this stock and revised its target price from $161 to $80.
For the past year, the stock price of Dexcom Inc fluctuated between $57.52 and $93.25. Currently, Wall Street analysts expect the stock to reach $81.36 within the next 12 months. Dexcom Inc [NASDAQ: DXCM] shares were valued at $75.34 at the most recent close of the market. An investor can expect a potential return of 7.99% based on the average DXCM price forecast.
Analyzing the DXCM fundamentals
According to Dexcom Inc [NASDAQ:DXCM], the company’s sales were 4.30B for trailing twelve months, which represents an 15.21% jump. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.18%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.26 and Total Capital is 0.17. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 74.65 points at the first support level, and at 73.97 for the second support level. However, for the 1st resistance point, the stock is sitting at 75.91, and for the 2nd resistance point, it is at 76.49.
Ratios To Look Out For
It is important to note that Dexcom Inc [NASDAQ:DXCM] has a current ratio of 1.52. In addition, the Quick Ratio stands at 1.35 and the Cash Ratio stands at 0.35. Considering the valuation of this stock, the price to sales ratio is 6.87, the price to book ratio is 11.48 and price to earnings (TTM) ratio is 52.74.
Transactions by insiders
Recent insider trading involved Brown Michael Jon, EVP, Chief Legal Officer, that happened on Aug 15 ’25 when 500.0 shares were sold. Director, FOLETTA MARK G completed a deal on Aug 15 ’25 to sell 2750.0 shares. Meanwhile, Officer MICHAEL BROWN bought 500.0 shares on Aug 15 ’25.
